Allopurinol use and risk of multiple sclerosis

Ida M. Heerfordt(Frederiksberg Hospital), Henrik Horwitz(University of Copenhagen), Melinda Magyari(University of Copenhagen), Josefine Windfeld‐Mathiasen(Frederiksberg Hospital), Elisabeth Framke(Copenhagen University Hospital)
Multiple Sclerosis and Related Disorders
January 27, 2025
10.1016/j.msard.2025.106299
Cited by 4

Related Papers

Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis
|JAMA Neurology|2021|237
Apparent changes in the epidemiology and severity of multiple sclerosis
|Nature Reviews Neurology|2021|209
Comorbidity in Multiple Sclerosis
|Frontiers in Neurology|2020|204
Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women
|Neurology|2018|183